Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Calcitonin, calcitonin gene-related peptide (CGRP), adrenomedullin (ADM), and amylin belong to a unique group of peptide hormones important for homeostasis in diverse tissues. Calcitonin is essential for calcium balance, whereas CGRP and ADM are important for neurotransmission and cardiovascular and respiratory regulation. Based on phylogenetic analysis, we identified intermedin as a novel member of the calcitonin/CGRP peptide family. Analysis of intermedin expression indicated that intermedin is expressed primarily in the pituitary and gastrointestinal tract. Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors and competed with labeled CGRP for binding to its receptors in these cells. In addition, treatment of 293T cells expressing recombinant calcitonin receptor-like receptor (CRLR) and one of the three receptor activity-modifying proteins (RAMPs) showed that a CRLR/RAMP receptor complex is required for intermedin signaling. In contrast to CGRP and ADM, which exhibited a preferential stimulation of CRLR when co-expressed with RAMP1 and RAMP2 or RAMP3, respectively, intermedin represents a nonselective agonist for the RAMP coreceptors. In vivo studies demonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats via interactions with the CRLR/RAMP receptor complexes. Furthermore, in vivo treatment in mice with intermedin led to suppression of gastric emptying activity and food intake. Thus, identification of intermedin as a novel member of the calcitonin/CGRP peptide family capable of signaling through CRLR/RAMP receptor complexes provides an additional player in the regulation of peripheral tissues by CRLR and will allow development of new therapeutic agents for pathologies associated with diverse vascular and gastrointestinal disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 2004, two groups discovered the mammalian gene ADM2, which encodes a peptide with high similarity to adrenomedullin, and was named intermedin or adrenomedullin 2 (177, 195).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
In the citing paper
“Roh et al. found that, in the rat, intermedin is primarily expressed in the pituitary and gastrointestinal tract and showed that intraperitoneal administration of intermedin decreased blood pressure in both normal and spontaneously hypertensive rats (98, 177).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
In the citing paper
“Later studies have shown that CRLR/RAMP complex also functions as receptor for intermedin, which binds in a nonselective manner to either of the three RAMPs/CRLR dimers (177).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
Citations
Cites
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302
Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma
Kitamura, K., Kangawa, K., Kawamoto, M., Ichiki, Y., Nakamura, S., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1451 · Cited by 2,192
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Amara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
Activation of Orphan Receptors by the Hormone Relaxin
Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., & Hsueh, A. J. W. (2002) · Science · doi:10.1126/science.1065654 · Cited by 786
Self-citationHsu, S. Y., & Hsueh, A. J. W. (2001) · Nature Medicine · doi:10.1038/87936 · Cited by 650
Self-citationCloning and Characterization of cDNA Encoding a Precursor for Human Adrenomedullin
Kitamura, K., Sakata, J., Kangawa, K., Kojima, M., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1881 · Cited by 605
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Research works printed but not linked: 6
- Copp, 1994, Clin. Investig. Med., 17, 268
- Mulder, 2000, Am. J. Physiol., 278, E684
- Chiba, 1989, Am. J. Physiol., 256, E331
- Eguchi, 1994, Endocrinology, 135, 2454, 10.1210/endo.135.6.7988431 · doi:10.1210/endo.135.6.7988431 · Paper page
- Reidelberger, 2002, Am. J. Physiol., 282, R1395
- Meeran, 1997, J. Clin. Endocrinol. Metab., 82, 95
Cited by
Items 301–400 of 446
Musa, H., Hendrikse, E. R., Brimble, M. A., Garelja, M. L., Watkins, H. A., Harris, P. W. R., & Hay, D. L. (2019) · Biochemistry · doi:10.1021/acs.biochem.9b00571 · Cited by 9
Ma, S., Yan, F., & Hou, Y. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041537 · Cited by 11
“Intermedin (IMD), also known as adrenomedullin 2 (ADM2), was identified by Roh [9] and Kobayashi [10] at almost the same time.”
BackgroundIntermedin: A Skin Peptide that Is Downregulated in Atopic Dermatitis
Kindt, F., Wiegand, S., Loeser, C. R., Nilles, M., Niemeier, V., Hsu, S. Y., Steinhoff, M. S., Kummer, W., Gieler, U., & Haberberger, R. V. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700576 · Cited by 9
“IMD interacts with all three CLR/RAMP complexes with highest affinity for CLR/RAMP1 or CLR/RAMP3 (Chang et al., 2004; Roh et al., 2004).”
BackgroundMethodSelf-citationInvolvement of adrenomedullin in the attenuation of acute morphine-induced analgesia in rats
Wang, D., Huo, Y., Quirion, R., & Hong, Y. (2014) · Peptides · doi:10.1016/j.peptides.2014.01.009 · Cited by 9
Vascular dysfunction of postural tachycardia syndrome in children
Bai, W., Chen, S., Jin, H., & Du, J. (2018) · World Journal of Pediatrics · doi:10.1007/s12519-017-0104-8 · Cited by 9
The Preclinical Pharmacology of BIBN4096BS, a CGRP Antagonist
Hay, D. L., & Poyner, D. R. (2005) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2005.tb00155.x · Cited by 9
Adipose ADM2 ameliorates NAFLD via promotion of ceramide catabolism
Wang, P., Zhang, S., Dong, Y., Zeng, G., Liu, H., Wang, X., Jiang, C., & Li, Y. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.09.010 · Cited by 8
“Previous results have shown that ADM2 can activate down-stream signals of CRLR, but cannot activate downstream signals of CT, indicating that CRLR is an endogenous receptor of ADM2 23 .”
Wang, D., Yang, Z., Wu, P., Li, Q., Yu, C., Yang, Y., Du, Y., Jiang, M., & Ma, J. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03229-2 · Cited by 8
Dong, Y.-L., Vegiraju, S., & Yallampalli, C. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00059.2005 · Cited by 9
Velard, F., Chatron-Colliet, A., Come, D., Kioon, M. D. A., Lin, H., Hafsia, N., Cohen-Solal, M. E., Ea, H., & Lioté, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-73924-1 · Cited by 8
Liu, K., Shi, R., Wang, S., Liu, Q., Zhang, H., & Chen, X. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.724777 · Cited by 8
Higuchi, S., Wood, C. P., Nasiri, R. H., Giddla, L. J., Molina, V., Diarra, R., DiPatrizio, N. V., Kawamura, A., & Haeusler, R. A. (2023) · Endocrinology · doi:10.1210/endocr/bqad116 · Cited by 8
Zhang, Y.-R., Liu, S., Chen, Y., Zhang, L., Ji, D.-R., Zhao, J., Yu, Y.-R., Jia, M.-Z., Tang, C., Huang, W., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117342 · Cited by 9
Xiong, W., Qiu, S., Xu, L., Zhang, C., Yi, Y., Wu, Q., Huang, L., Liu, S., Wu, B., Peng, L., et al. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12416 · Cited by 8
“27 Roh et al.(22) also described a fragment of IMD, IMD17–47, thought to be a functional antagonist of the peptide.”
BackgroundTang, B., Zhong, Z., Shen, H., Wu, H., Xiang, P., & Hu, B. (2014) · Peptides · doi:10.1016/j.peptides.2014.06.009 · Cited by 8
Hai, S., Hao, Z. Q., Fu, X. B., Hua, X. D., Ma, Z., Ai, F. L., Feng, Z., Wang, K., Li, W., & Li, B. (2018) · Oncology Letters · doi:10.3892/ol.2018.8033 · Cited by 8
“CGRP may serve its role through binding with calcitonin receptor like receptors/receptor activity modifying protein receptor complexes (RAMPs) (16).”
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00028-9 · Cited by 16
Sekiguchi, T. (2022) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2022.114123 · Cited by 8
Cyclostome and chondrichthyan adrenomedullins reveal ancestral features of the adrenomedullin family
Wong, M. K., & Takei, Y. (2009) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2009.07.006 · Cited by 8
Soultanova, A., Mikulski, Z., Pfeil, U., Grau, V., & Kummer, W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163483 · Cited by 8
Martı́nez, V., Wang, L., & Taché, Y. (2005) · Peptides · doi:10.1016/j.peptides.2005.11.003 · Cited by 8
Sekar, R., & Chow, B. (2013) · Hormone and Metabolic Research · doi:10.1055/s-0033-1353155 · Cited by 10
Schlier, A., Schreckenberg, R., Abdallah, Y., Krasteva‐Christ, G., Piper, H. M., Pfeil, U., Kummer, W., & Schlüter, K. (2009) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2008.11.001 · Cited by 8
Kong, L., Xiao, F., Wang, L., Li, M., Wang, D., Feng, Z., Huang, L., Wei, Y., Li, H., Liu, F., et al. (2020) · MedComm · doi:10.1002/mco2.9 · Cited by 7
Rational design of highly stabilized and selective adrenomedullin analogs
Jülke, E., Fischer, J., Els‐Heindl, S., Bierer, D. E., Flamme, I., Köbberling, J., Riedl, B., & Beck‐Sickinger, A. G. (2023) · Journal of Peptide Science · doi:10.1002/psc.3530 · Cited by 7
Role of Adrenomedullin in the Growth and Differentiation of Stem and Progenitor Cells
Larráyoz, I. M., Ochoa‐Callejero, L., García-Sanmartín, J., Vicario‐Abejón, C., & Martínez, A. (2012) · International review of cytology · doi:10.1016/b978-0-12-394308-8.00005-4 · Cited by 10
“Intermedin, also termed adrenomedullin 2, has been also identified as a novel member of this family (Roh et al., 2004; Takei et al., 2004).”
BackgroundXue, C.-D., Chen, Y., Ren, J.-L., Zhang, L., Liu, X., Yu, Y.-R., Tang, C., & Qi, Y. (2019) · Peptides · doi:10.1016/j.peptides.2019.170131 · Cited by 7
Zhou, Y., Sun, H., Chang, J.-R., Ding, L., Gao, Q., Tang, C., Zhu, G., & Zhou, Y. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214533882 · Cited by 7
“For instance, IMD stimulates prolactin, oxytocin and vasopressin release,(28,39,40) induces anti-diuresis and anti-natriuresis, suppresses food and water intake,(5) growth hormone release and gastric emptying activity.(2) Intracerebroventricular administration of IMD causes an increase in BP,(5) which is opposite to i…”
BackgroundInfluentialDesensitization and re-sensitization of CGRP receptor function in human neuroblastoma SK-N-MC cells
Pin, S. S., Xu, C., & Bahr, B. A. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.08.014 · Cited by 7
The protective role of intermedin in promoting angiogenesis during renal fibrosis
Dong, H., Zhou, Y., Wang, Y., Zhou, Q., Zhang, Y., Gan, X., Luo, Y., & Li, R. (2018) · Gene · doi:10.1016/j.gene.2018.11.057 · Cited by 7
Synergistic activation of the human adrenomedullin gene promoter by Sp1 and AP-2α
Zhang, Y., Li, Y., Shibahara, S., & Takahashi, K. (2007) · Peptides · doi:10.1016/j.peptides.2007.07.015 · Cited by 7
Zavorsky, G. S., & Anholm, J. D. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00814.2010 · Cited by 7
Nag, K., Sultana, N., & Hirose, S. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.116 · Cited by 6
Chauhan, M., Betancourt, A., Balakrishnan, M. P., Yallampalli, U., Dong, Y., Fox, K. A., Belfort, M. A., & Yallampalli, C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1798 · Cited by 6
“However, ADM2 is shown to be a nonselective agonist for RAMPs but exhibits greater potency with CRLR/RAMP1 and CRLR/RAMP3 (11).”
BackgroundInfluentialCalcitonin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Hay, D. L., Poyner, D. R., & Walker, C. S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2019.4 · Cited by 6
Huang, T., Su, J., Wang, X., Shi, N., Zhang, X., He, J., Li, J., Zhang, J., & Wang, Y. (2024) · Animals · doi:10.3390/ani14071058 · Cited by 6
“Despite low primary amino acid sequence similarity (about 20%), they share conserved secondary structures, including a six-or seven-membered ring formed by disulfide bonds and an α -helix configuration, culminating in a categorization within the calcitonin family [8–12].”
BackgroundMulti-biological functions of intermedin in diseases
Yang, Z., Li, H., Wu, P., Li, Q., Yu, C., Wang, D., & Li, W. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1233073 · Cited by 6
“RAMPs could alter CLR ligand selectivity through allosteric effects and direct peptide contacts (Booe et al., 2018).”
BackgroundInfluentialPires, A. L., Pinho, M., Alves, B. S., Pinho, S., Sena, C. M., Seiça, R. M. F., & Leite-Moreira, A. F. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.240812 · Cited by 6
“Among these, the newest member of the calcitonin gene-related peptide (CGRP) family, named intermedin (IMD) or adrenomedullin-II, is gaining increasing interest (Roh et al. 2004; Takei et al. 2004).”
BackgroundWong, C.-W., Wai‐Sum, O., & Tang, F. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-13 · Cited by 7
Nag, K., Sultana, N., Kato, A., Drannik, A. G., Nakamura, N., Kutsuzawa, K., Hirose, S., & Akaike, T. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.04.029 · Cited by 6
“Pufferfish AM1, AM2, and AM5 were custom synthesized by Peptide Institute (Osaka, Japan).”
BackgroundInfluentialLow-dose adrenomedullin-2/intermedin(8–47) reduces pulmonary ischemia/reperfusion injury
Körner, C., Kuchenbuch, T., Pfeil, U., Jung, K., Padberg, W. M., Kummer, W., Mühlfeld, C., & Grau, V. (2014) · Peptides · doi:10.1016/j.peptides.2014.09.022 · Cited by 6
Kato, J., & Kitamura, K. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00185-8 · Cited by 6
Takei, Y., Ogoshi, M., Wong, M. K., & Nobata, S. (2009) · Springer eBooks · doi:10.1007/978-90-481-2909-6_1 · Cited by 7
“AM2 was also discovered by Hsu and his colleagues and named intermedin (Roh et al. 2004).”
BackgroundActivation of Calcitonin Receptor and Calcitonin Receptor-like Receptor by Membrane-anchored Ligands
Chang, C. L., Park, J., & Hsu, S. Y. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.020040 · Cited by 5
Self-citationChang, C. L., Cai, Z. P., & Hsu, S. Y. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003440 · Cited by 5
“On the other hand, the hypotensive effect of wild-type adrenomedullin at the same dose returned to the basal level within 2 h [31].”
BackgroundSelf-citationLi, P., Shi, L., Han, Y., Zhao, Y.-T., Qi, Y., & Wang, B. (2016) · Medicine · doi:10.1097/md.0000000000003422 · Cited by 5
“Unlike BNP, the primary source of plasma IMD remains unclear.(21) Although there are studies demonstrating that IMD is involved in the gene expression of BNP in cardiac tissue, how IMD affects plasma BNP is not addressed yet.”
BackgroundMechanism of adrenomedullin 2/intermedin mediated vasorelaxation in rat main pulmonary artery
Telli, G., Eraç, Y., Tel, B. C., & Gümüşel, B. (2018) · Peptides · doi:10.1016/j.peptides.2018.03.015 · Cited by 5
“Although AM2/IMD generally interacts with both CGRP and AM receptors, it has been also shown that AM2/IMD-mediated vasorelaxation occurs via mostly CGRP receptors [1,32].”
BackgroundThe Cardiopulmonary Effects of the Calcitonin Generelated Peptide Family
Telli, G., Tel, B. C., & Gümüşel, B. (2020) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2019.47123 · Cited by 5
“Analysis of responses to adrenomedullin-(13-52) in the pulmonary vascular bed of rats.”
IMD/ADM21-47, a factor that improves embryo quality
García-Hernández, J., Castro-Valenzuela, B. E., Rodríguez-Borbón, A., Grado-Ahuir, J. A., & Burrola-Barraza, E. (2020) · Theriogenology · doi:10.1016/j.theriogenology.2020.01.049 · Cited by 5
Morales-Morales, O. O., Sánchez‐Ramírez, B., Castro-Valenzuela, B. E., Infante‐Ramírez, R., & Burrola-Barraza, E. (2022) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00647-0 · Cited by 6
Rat intermedin1-47 does not improve functional recovery in postischemic hearts
Münzel, G., Schlier, A., Schreckenberg, R., Abdallah, Y., & Schlüter, K. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0680-4 · Cited by 5
Yamaç, A. H., Bacaksız, A., İsmailoğlu, Z., Kucukbuzcu, S., Sevgili, E., Asoğlu, E., Nasıfov, M., Jafarov, P., Erdoğan, E., & Göktekin, Ö. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-182 · Cited by 4
“Roh and colleagues identified a new peptide that possesses similar characteristics with adrenomedullin and named it IMD due to its primarily expression in the intermediate lobe of the anterior pituitary glands [16].”
BackgroundStavreus-Evers (2008) · Molecular Medicine Reports · doi:10.3892/mmr_00000053 · Cited by 4
“AM belongs to the calcitonin family, which comprises six known members: calcitonin, amylin, two calcitonin-gene related peptides (CGRP-· and CGRP-ß), AM and intermedin (3,4).”
Zhang, Y., Tang, N., & Zhou, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12373 · Cited by 4
Physiological and Pathophysiological Role of Islet Amyloid Polypeptide (IAPP, Amylin)
Westermark, G. T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_15 · Cited by 4
“IAPP belongs to the calcitonin family of peptides also including calcitonin [57], calcitonin gene-related peptides (CGRP) [58], adrenomedullin [59] and intermedin [60].”
BackgroundCameron, M. S., Nobata, S., Takei, Y., & Donald, J. A. (2014) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2014.09.034 · Cited by 4
“In contrast, other studies have shown that AMmediates endothelium-independent vasodilation involving cAMP and K channels (Roh et al., 2004; Bayram et al., 2010).”
BackgroundResultInfluentialMolecular cloning and expression of preproadrenomedullin gene from common carp Cyprinus carpio L.
Kono, T., & Sakai, M. (2004) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2004.05.002 · Cited by 4
Calcitonin Gene Family of Peptides
Hu, M. I.-N., & Gagel, R. F. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00055-0 · Cited by 4
Receptor‐Mediated Events in the Microcirculation
Watts, S. W., Kanagy, N. L., & Lombard, J. H. (2008) · Comprehensive physiology · doi:10.1002/cphy.cp020407 · Cited by 4
Chang, C. L., Lo, W.-C., Lee, T.-H., Sung, J.-Y., & Sung, Y.-J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1047498 · Cited by 3
“Importantly, Adm2 is also highly expressed in oocytes (1, 36), and we have shown that ADM2 is important for maintaining the integrity of cumulus-oocyte complex (COC) in vitro and normal cyclin D2 expression in follicles (38).”
BackgroundResultSelf-citationYi, X., Li, G., Li, G., Xu, J., Zhang, T., Li, M., Gao, C., Fu, M., Zheng, P., & Chu, X. (2025) · Scientific Reports · doi:10.1038/s41598-025-91319-y · Cited by 4
“ADM2 is a member of the calcitonin gene-related peptide (CGRP)/calcitonin family of hormones that play a role in the regulation of food-water intake 32 .”
Unique Biased Agonism Profile of βCGRP on CGRP Family Receptors
Mennen, G., Ying, Z., Fletcher, M. M., Razzak, M. A., Humphrys, L. J., Josephs, T. M., Sexton, P. M., Wootten, D. L., & Zhao, P. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00855 · Cited by 3
Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation
Chang, C. L., Cai, Z. P., & Hsu, S. Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1040951 · Cited by 3
“In a separate experiment, we compared the viscosity of ADE651 to a control chimeric ADM/ADM2 peptide (i.e., ADE410) which does not form a liquid gel at 6–20% level.”
BackgroundInfluentialSelf-citationWhite, M. M., & Samson, W. K. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.001 · Cited by 3
Charles, C. J., Rademaker, M. T., Nicholls, M. G., & Richards, M. (2010) · Peptides · doi:10.1016/j.peptides.2010.02.010 · Cited by 3
Calcitonin Gene-Related Peptide Receptor
Hay, D. L. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60177-1 · Cited by 3
Intermedin 1-53 Inhibits Myocardial Fibrosis in Rats by Down-Regulating Transforming Growth Factor-β
Fang, J., Luan, J., Zhu, G., Qi, C., Yang, Z., Zhao, S., Li, B., Zhang, X., Guo, N., Li, X., et al. (2017) · Medical Science Monitor · doi:10.12659/msm.898522 · Cited by 3
“[3] and others [4], who used phylogenetic analysis to retrieve GenBank data using the primary and secondary structure specific to this superfamily.”
MethodNishikimi, T., Kuwahara, K., Nakagawa, Y., Kangawa, K., & Nakao, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803111-7.00002-6 · Cited by 9
Intermedin and the unfolded protein response
Luft, F. C. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0827-2 · Cited by 3
Takei, Y. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-385095-9.00198-6 · Cited by 3
Role of adrenomedullin2/ intermedin in pregnancy induced vascular and metabolic adaptation in mice
Yallampalli, C., Betancourt, A., Mishra, A., Pennington, K. A., Ruano, S. H., Tacam, M. J., & Chauhan, M. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1116042 · Cited by 2
“However, majority of the AM2 effects are shown to involve RAMP2 and RAMP3 (Roh et al., 2004; Hay et al., 2018; Garelja and Hay, 2022).”
BackgroundInfluentialZhao, J., Han, L., Zhang, Y.-R., Liu, S., Ji, D.-R., Wang, R., Yu, Y.-R., Jia, M.-Z., Chai, S., Tang, H., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17091204 · Cited by 2
“Intermedin (IMD), also known as adrenomedullin 2 (ADM2), is a member of the calcitonin gene-related peptide (CGRP) superfamily discovered in 2004, which is a paracrine/autocrine bio-active polypeptide [28,29].”
BackgroundHemodynamic, Hormonal, and Renal Actions of Adrenomedullin-5 in Normal Conscious Sheep
Charles, C. J., Rademaker, M. T., & Richards, M. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31821a9473 · Cited by 2
“In 2004, 2 groups independently identified a structurally related mammalian peptide known as AM-2 (or intermedin).(6,7) We have previously reported the hemodynamic, hormonal, and renal actions of AM-2 in both normal conscious sheep(8) and sheep with pacinginduced heart failure.”
BackgroundPfeil, U., Bharathala, S., Murtaza, G., Mermer, P., Papadakis, T., Boening, A., & Kummer, W. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2473-z · Cited by 2
“This expression profile points towards preferential AM rather than AM-2 and CGRP signalling, seen both from the ligand and from the receptor side, since the rank order of potency for stimulating CRL/RAMP2 complexes is AM>AM-2 =CGRP (Roh et al. 2004).”
BackgroundFindlay, D. M., Sexton, P. M., & Martin, T. J. (2016) · Endocrinology: Adult and Pediatric · doi:10.1016/b978-0-323-18907-1.00058-5 · Cited by 2
Fish-derived peptides: from fish to human physiology and diseases
Takahashi, K., & Kawauchi, H. (2004) · Peptides · doi:10.1016/j.peptides.2004.06.021 · Cited by 2
Vaudry, H., & Nahon, J. (2009) · Peptides · doi:10.1016/j.peptides.2009.09.014 · Cited by 2
Takahashi, K. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50214-2 · Cited by 2
Jiang, J., Chen, D., Xie, S., Dong, Q., Yu, Y., Xu, Y., & Zhang, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-915958/v1 · Cited by 2
Bao, W., Lian, H., & Zhang, A. (2022) · International Urology and Nephrology · doi:10.1007/s11255-022-03240-2 · Cited by 1
“IMD is a medium-tolarge molecular weight polypeptide [3], which is difficult to remove by HD.”
BackgroundAdrenomedullin in pulmonary hypertension
Nishikimi, T., Kinoshita, H., Inazumi, H., Kanamori, T., Yanagisawa, H., Moriuchi, K., & Nakagawa, Y. (2024) · Danish Medical Journal · doi:10.61409/a07240498 · Cited by 1
Genetic parameters and genomic insights for meat colour traits of Canadian crossbred beef cattle
Virtuoso, M. C. S., Aalhus, J. L., Juarez, M. M., López-Campos, Ó., Bruce, H. L., Li, C., Basarab, J. A., Plastow, G. S., & Valente, T. S. (2025) · Canadian Journal of Animal Science · doi:10.1139/cjas-2024-0074 · Cited by 1
Ji, D.-R., Chen, Y., Zhu, H.-X., Liu, S., Wu, N., Zhang, Y.-R., Zhao, J., Yu, Y.-R., Jia, M.-Z., Han, L., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18101503 · Cited by 1
“IMD exerts its biological effects by combining with calcitonin receptor-like receptor (CRLR) and receptor activity modifying protein (RAMP)1/2/3 [11].”
He, Y. L., Jing, S., Zhang, K., Yao, K., Niu, J., Ge, Y., Su, X., & Qiao, X. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2610795 · Cited by 1
“Intermedin (IMd) or adrenomedullin 2 (adM2), an endocrine/paracrine small peptide, is primarily distributed in human tissues including the kidneys, heart, lungs, and brain [20,21].”
Caracterización de un modelo de colitis en ratones knockout inducibles para adrenomedulina
Martínez-Herrero, S. (2014) · Cited by 1
Güzel, S., & Gunes, N. (2014) · Brazilian Journal of Poultry Science · doi:10.1590/1516-635x1604375-380 · Cited by 1
Utilization of genetic information for the dissection of complex diseases or traits
Wang, J.-G., & Liu, M. (2011) · Hypertension Research · doi:10.1038/hr.2011.174 · Cited by 1
Intermedin and calcitonin gene-related peptide fail to shine in acute coronary syndrome
Morrice, K., Bell, D., Agnew, C., & Harbinson, M. (2014) · IJC Metabolic & Endocrine · doi:10.1016/j.ijcme.2014.10.002 · Cited by 1
Structural Bioinformatics Analysis On Diabetes Associated Proteins
Colak, E. (2016) · Southeast Europe Journal of Soft Computing · doi:10.21533/scjournal.v5i1.106 · Cited by 1
Li, H., Xiao, C., Bian, Y., Bai, R., & Fen, G. (2017) · European Journal of Inflammation · doi:10.1177/1721727x17744096 · Cited by 1
“15 IMD(1-53) exerts cardioprotective effect against myocardial I/R injury through the activation of the Akt/ GSK-3-beta signaling pathway to inhibit mitochondria-mediated myocardial apoptosis.”
BackgroundCharles, C. J., Jardine, D. L., Rademaker, M. T., & Richards, M. (2019) · Physiological Reports · doi:10.14814/phy2.14096 · Cited by 1
“10 | e14096 Page 1 are consistently observed in several species including rats (Roh et al. 2004; Takei et al. 2004; Fujisawa et al. 2006, 2007) and sheep (Charles et al. 2006).”
BackgroundInfluentialIntermedin promotes hepatic carcinoma cell proliferation through upregulation of miR-155.
Hai, S., Hao, Z. Q., Fu, X. B., Hua, X. D., Hong, Z., Ai, F. L., Feng, Z., Wang, K., Li, W. X., & Li, B. (2018) · Europe PMC (PubMed Central) · Cited by 1
The role of angiogenic factors in first trimester pregnancy losses
Eskicioğlu, F., Özbilgin, K., Taşkend, S., & Gökmen, T. (2017) · Clinical and Experimental Obstetrics & Gynecology · doi:10.12891/ceog3598.2017 · Cited by 1
Calcitonin receptors in GtoPdb v.2021.2
Hay, D. L., Poyner, D. R., & Walker, C. S. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2021.2 · Cited by 1
Martin, T. J., Findlay, D. M., & Sexton, P. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00057-5 · Cited by 2
Turner, A. J. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60179-5 · Cited by 1
The Increased Plasma Levels of Intermedin in Patients with Type 2 Diabetes Mellitus
Liu, F., Duan, J., Teng, X., & Peng, D.-Q. (2022) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2022.271 · Cited by 1
Calcitonin receptors in GtoPdb v.2023.1
Garelja, M. L., Hay, D. L., Poyner, D. R., & Walker, C. S. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f11/2023.1 · Cited by 3
Andreia, M. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/47t6-7a17 · Cited by 1
Takei, Y. (2006) · Elsevier eBooks · doi:10.1016/b978-012369442-3/50177-x · Cited by 1
Metadata
- Authors
- Roh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Hsu, Sheau Yu Teddy
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 279
- Issue
- 8
- Pages
- 7264-7274
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044285853
- Cited by
- 443
- References
- 37
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 12 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 15 · 2018: 22 · 2017: 25 · 2016: 23 · 2015: 20 · 2014: 22 · 2013: 24 · 2012: 24
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6102 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Stanford University
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- intermedin, calcitonin gene-related peptide, calcitonin, adrenomedullin, amylin, calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, RAMP3, cAMP signaling, blood pressure regulation, hypertension, gastric emptying, dietary intake, pituitary gland, gastrointestinal tract
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Blood Pressure, Calcitonin, Cell Line, Cloning, Molecular, Dose-Response Relationship, Drug, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Peptides, Phylogeny, Protein Binding, Rats, Inbred SHR, Time Factors, Tissue Distribution, Transfection, Blotting, Northern, Signal Transduction, Calcitonin Gene-Related Peptide, Rats, Sprague-Dawley, Sequence Homology, Amino Acid, Receptors, Calcitonin Gene-Related Peptide, DNA, Complementary, Peptide Hormones, Cell Line, Tumor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.